Design, Synthesis, and Computational Evaluation of 3,4-Dihydroquinolin-2(<i>1H</i>)-One Analogues as Potential VEGFR2 Inhibitors in Glioblastoma Multiforme
<b>Background/Objectives</b>: Glioblastoma multiforme (GBM), an aggressive and deadly brain tumour, presents significant challenges in achieving effective treatment due to its resistance to current therapies and poor prognosis. This study aimed to synthesise and evaluate 23 novel analogu...
Saved in:
| Main Authors: | Shafeek Buhlak, Nadeem Abad, Jihane Akachar, Sana Saffour, Yunus Kesgun, Sevval Dik, Betul Yasin, Gizem Bati-Ayaz, Essam Hanashalshahaby, Hasan Türkez, Adil Mardinoglu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/2/233 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
VEGFA, VEGFR1, VEGFR2 serum and cerebrospinal fluid concentration in patients with acute leukemia
by: E. I. Zakharko, et al.
Published: (2024-04-01) -
Cinobufagin inhibits hepatocellular carcinoma EMT-like stemness via VEGF/VEGFR2 autocrine signaling
by: Mingjun Ye, et al.
Published: (2025-05-01) -
Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studies
by: Mohammed S. Taghour, et al.
Published: (2022-12-01) -
In Silico Analysis of Triamterene as a Potential Dual Inhibitor of VEGFR-2 and c-Met Receptors
by: Stuart Lutimba, et al.
Published: (2024-12-01) -
Post-treatment Assessment of Glioblastoma Multiforme: Imaging with Fluorodeoxyglucose, Sestamibi, and Choline
by: Chjoong Howe Tan, et al.
Published: (2012-01-01)